首页> 外文OA文献 >368: Longer follow up of patients (pts) with advanced chronic lymphocytic leukemia (CLL) treated with nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation (HCT)

【2h】

368: Longer follow up of patients (pts) with advanced chronic lymphocytic leukemia (CLL) treated with nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation (HCT)

机译：368：对接受非清髓性调理和同种异体造血细胞移植（HCT）治疗的晚期慢性淋巴细胞性白血病（CLL）的患者（pts）进行更长的随访

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Sorror M.L.; Storer B.; Sandmaier B.M.; Maris M.B.; Shizuru J.; Niederwieser D.; Agura E.; Chauncey T.; Maziarz R.; Pulsipher M.; McSweeney P.; Wade J.; Bruno B.; Langston A.; Blume K.; Storb R.; Maloney D.G.;
展开▼
作者单位

展开▼
年度 2007
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Five-year follow-up of patients with advanced chronic lymphocytic leukemia treated with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning. [J] . Sorror ML, Storer BE, Sandmaier BM, Journal of Clinical Oncology . 2008,第30期

机译：非清髓条件治疗后的同种异体造血细胞移植治疗的晚期慢性淋巴细胞性白血病患者的五年随访。
2. Long-Term Outcome of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Chronic Lymphocytic Leukemia (CLL): 10-Year Follow-up of the Gcllsg CLL3X Trial [J] . Kramer Isabelle, Stilgenbauer Stephan, Dietrich Sascha, Blood: The Journal of the American Society of Hematology . 2016,第22期

机译：异基因造血干细胞移植（HSCT）治疗慢性淋巴细胞性白血病（CLL）的长期结果：Gcllsg CLL3X试验的10年随访
3. Allogeneic Hematopoietic Cell Transplantation (HCT) Results in Better Time to Next Therapy (TTNT) Than Chemotherapy (CT) in Chronic Lymphocytic Leukemia (CLL) [J] . Rondon Carlos H. Silva, Whitton Thomas, William Basem M., Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2016,第3Suppla1期

机译：在慢性淋巴细胞性白血病（CLL）中，同种异体造血细胞移植（HCT）比化学疗法（CT）拥有更好的下一次治疗（TTNT）时间
4. THE EFFECT OF INHIBITORY KILLER-CELL IG-LIKE RECEPTOR (IKIR) MATCHING IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION (HCT) [C] . David Senitzer, Joel Y. Sun, Arisa Oki, Clinical Histocompatibility Workshop. . 2009

机译：同种异体造血细胞移植（HCT）中抑制杀伤细胞IG样受体（IKIR）匹配的影响
5. Folate status and risk of relapse following allogeneic hematopoietic cell transplant for chronic myelogenous leukemia. [D] . Robien, Kimberly Ziemer. 2003

机译：异基因造血细胞移植治疗慢性粒细胞白血病后的叶酸状况和复发风险。
6. Five-Year Follow-Up of Patients With Advanced Chronic Lymphocytic Leukemia Treated With Allogeneic Hematopoietic Cell Transplantation After Nonmyeloablative Conditioning [O] . Mohamed L. Sorror, Barry E. Storer, Brenda M. Sandmaier, -1

机译：非清髓条件治疗后的同种异体造血细胞移植治疗晚期慢性淋巴细胞性白血病患者的五年随访
7. Early Results of a Phase II Study Adding Peri-Transplant Rituximab to Nonmyeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation (HCT) for Patients (PTS) with High-Risk Fludarabine-Refractory Chronic Lymphocytic Leukemia (Cll) [O] . Sorror M.L., Storer B., Sandmaier B.M., 2012

机译：高风险氟达拉滨难治性慢性淋巴细胞性白血病（Cll）患者（PTS）的非清髓性调节和同种异体造血细胞移植（HCT）的II期研究的早期结果

368: Longer follow up of patients (pts) with advanced chronic lymphocytic leukemia (CLL) treated with nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation (HCT)

著录项

引文网络

相似文献

相关主题

期刊订阅